| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $861.7M | +13.9% |
| Cost of Revenue | $371.7M | +11.7% |
| Gross Profit | $490.1M | +15.7% |
| R&D Expense | $193.4M | +22.9% |
| SG&A Expense | $95.6M | +13.3% |
| Operating Income | $9.1M | +137.4% |
| Interest Expense | $48.4M | +32.4% |
| Pre-tax Income | -$38.1M | +42.9% |
| Income Tax | -$12.0M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $254.3M | +12.8% |
| Accounts Receivable | $96.8M | +10.8% |
| Current Assets | $382.9M | +9.0% |
| Total Assets | $3.09B | -0.6% |
| Current Liabilities | $131.1M | -14.4% |
| Long-term Debt | $925.3M | -0.6% |
| Total Liabilities | $1.19B | -4.9% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $150.7M | +6.8% |
| Capital Expenditures | $3.4M | -62.2% |
| Investing Cash Flow | -$119.1M | +81.4% |
| Financing Cash Flow | -$2.7M | -100.7% |
| Free Cash Flow | $147.3M | +11.5% |
| +46.8% |
| Net Income | -$26.1M | +41.0% |
| EPS (Basic) | -$0.31 | +41.5% |
| EPS (Diluted) | -$0.31 | +41.5% |
| Stockholders' Equity |
| $1.90B |
| +2.3% |